Okan Oktar

10PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in Turkey.

Yesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin

|May 09, 2025
Survival of patients with 2014 FIGO stage IIIC high-grade serous ovarian cancer who were treated with platin-based adjuvant chemotherapy.

Mehmet Ünsal, Meltem Yücesoy, Okan Oktar

|Dec 20, 2024
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?

Abdurrahman Alp Tokalioglu, Okan Oktar, Mehmet Unsal

|Jun 13, 2024
Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better than other high-risk HPV subtypes?

Abdurrahman Alp Tokalıoğlu, Aysun Alcı, Okan Oktar

|Feb 02, 2024
Defining the relationship between ovarian adult granulosa cell tumors and synchronous endometrial pathology: Does ovarian tumor size correlate with endometrial cancer?

Abdurrahman Alp Tokalioglu, Okan Oktar, Mustafa Sahin

|Dec 29, 2023
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study.

Okan Oktar, Vakkas Korkmaz, Alp Tokalıoğlu

Pageof 2